Abstract: 536 BASELINE CHOLESTEROL ABSORPTION MARKERS DO NOT PREDICT LDL-CHOLESTEROL REDUCTION BY EZETIMIBE/SIMVASTATIN IN SUBJECTS WITH FAMILIAL HYPERCHOLESTEROLEMIA; A POST-HOC ANALYSIS OF THE ENHANCE TRIAL

✍ Scribed by Jakulj, L; Vissers, M; Hutten, B; Groen, A; Lutjohann, D; Veltri, E; Kastelein, J

• Book ID: 118637116
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 86 KB
• Volume: 10
• Category: Article
• ISSN: 1567-5688
• DOI: 10.1016/s1567-5688(09)70276-4